MTOR and heart failure: Finally, we showed that mTOR inhibition prevented functional dysregulation in vitro (Figure 7), and that, using this information, mTOR inhibition led to a remarkable improvement in clinical status in a patient with the LMNA E161K mutation and severe heart failure.